menu
    • menu

    Company profile for Nura Bio

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Nura Bio (previously known as Proneurotech Inc.), we envision a world where the diagnosis of a neurological disorder comes with the hope of a cure. Expanding on recent breakthroughs in crucial neurodegenerative pathways, we are positioned to deliver transformative neuroprotective therapies to prevent and protect against neuronal loss and related neuroimmune dysregulation. Our research and development strategy is currently c...
    At Nura Bio (previously known as Proneurotech Inc.), we envision a world where the diagnosis of a neurological disorder comes with the hope of a cure. Expanding on recent breakthroughs in crucial neurodegenerative pathways, we are positioned to deliver transformative neuroprotective therapies to prevent and protect against neuronal loss and related neuroimmune dysregulation. Our research and development strategy is currently centered on two approaches: prevention of neuronal loss to preserve neurological function; and restoring the function of the neuron-glia axis to improve the nervous system’s immune surveillance capacity.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nura BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    161 Oyster Point Blvd, Suite 200, South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nurabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nurabio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nura Bio Expands Leadership Team with C-Suite Appointments
    Nura Bio Expands Leadership Team with C-Suite Appointments

    18 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250218204223/en

    BUSINESSWIRE
    18 Feb 2025
    Share Share
    Nura Bio Closes Series A Financing, Raising $140+ Million In Total Funding
    Nura Bio Closes Series A Financing, Raising $140+ Million In Total Funding

    17 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240917107266/en

    BUSINESSWIRE
    17 Sep 2024
    Share Share
    Nura Bio Initiates Ph I Trial for Oral, Brain-Penetrant SARM1 Inhibitor, NB-4746
    Nura Bio Initiates Ph I Trial for Oral, Brain-Penetrant SARM1 Inhibitor, NB-4746

    25 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230825982445/en

    BUSINESSWIRE
    25 Aug 2023
    Share Share
    Nura Reports Data Validating Conserved Mechanism of Inhibition of NAD Hydrolases
    Nura Reports Data Validating Conserved Mechanism of Inhibition of NAD Hydrolases

    13 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220913005518/en

    BUSINESSWIRE
    13 Sep 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search